Plain-English translation of NCT06487559 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a combination of two new medications called and in people with advanced liver cancer that has spread or cannot be removed with surgery. The trial will monitor how safe these medications are and how your body processes them over time. You would receive these medications as infusions into your vein every 3 weeks.
Liver cancer is a serious disease, and many people are diagnosed when it is already advanced. Some patients' cancers stop responding to current immunotherapy treatments, and researchers are looking for new medication combinations that might work better for these patients.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital or clinic regularly for about 2 years to receive infusions of the two medications every 3 weeks. Between visits, you would have frequent blood tests and imaging scans (such as CT or MRI) to monitor how the treatment is working and check for any side effects. The study involves more medical appointments and tests than standard care, so you should be prepared for a significant time commitment.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China